Guidelines for Australian Mycobacteriology Laboratories
DOI:
https://doi.org/10.33321/cdi.2006.30.6Keywords:
Mycobacterium tuberculosis, mycobacteriology laboratories, safety, guidelinesAbstract
Guidelines for Australian laboratories performing tuberculosis (TB) microscopy and culture have been developed through extensive consultation with expert groups. The aims of these guidelines are:
- to provide consensus recommendations on the infrastructure, equipment and work practices required by mycobacteriology laboratories;
- to inform laboratory administrations and governments of the necessary level of investment required to maintain modern mycobacteriology facilities; and
- to provide informal measures for reviewers inspecting mycobacteriology facilities.
These guidelines include safety recommendations based largely on the Australian/New Zealand Standard 2243.3 Safety in laboratories – Microbiological aspects and containment facilities. However, these standards have been rationalised and PC2 facilities with additional processes and precautions in place are recommended for the majority of TB investigations. Guidelines are also provided on staff training, education, health screening and vaccination. Certain procedures and work practices are recommended for mycobacteriology laboratories to guarantee safety, high-quality results, and prompt turnaround times. These Australian guidelines will be reviewed each 1–2 years and feedback from expert groups is welcomed.
Downloads
References
Roche P, Merianos A, the National TB Advisory Committee. Tuberculosis notifications in Australia, 1998. Commun Dis Intell 2001;25 254–260.
Tenover FC, Crawford JT, Huebner RE, Geiter LJ, Horsburgh CR Jr, Good RC. The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol 1993;31:767–770.
Association of State and Territory Public Health Laboratory Directors/Centers for Disease Control. Technical review. Mycobacterium tuberculosis: assessing your laboratory. Washington, DC: US Department of Health and Human Services, 1995.
Huebner RE, Good RC, Tokars JI. Current practices in mycobacteriology: results of a survey of state public health laboratories. J Clin Microbiol 1993;31:771–775.
Bird BR, Denniston MM, Huebner RE, Good RC. Changing practices in mycobacteriology: a follow-up survey of state and territorial public health laboratories. J Clin Microbiol 1996;34:554–559.
Dawson D. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 1998–1999. Commun Dis Intell 2001;25:261–265.
Frieden TR, Fujiwara PI, Washko RM, Hamburg MA . Tuberculosis in New York City – turning the tide. N Engl J Med 1995;333:229–233.
Australian/New Zealand Standard 2243.3 Safety in laboratories – Microbiological aspects and containment facilities.
National Pathology Accreditation Advisory Council. Standards for Pathology Laboratories. Canberra: Commonwealth Department of Health and Family Services, 1998.
The Public Health Service National Tuberculosis Reference Laboratory and the National Laboratory Network: minimum requirements, role and operation in a low-income country. Paris: International Union Against Tuberculosis and Lung Disease, 1998.
Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. Centers for Disease Control and Prevention. MMWR Recomm Rep 1994;43(No. RR–13):1–132.
Watterson SA, Drobniewski FA. Modern laboratory diagnosis of mycobacterial infections. J Clin Pathol 2000;53:727–732.
Centers for Disease Control and Prevention (CDC). Misdiagnoses of tuberculosis resulting from laboratory cross-contamination of Mycobacterium tuberculosis cultures— New Jersey, 1998. MMWR Morb Mortal Wkly Rep 2000;49:413–416.
Woods GL. Susceptibility testing for mycobacteria. Clin Infect Dis 2000;31:1209–1215.
National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes. Approved Standard. M24–A. Vol 23 No 18. Wayne PA: National Committee for Clinical Laboratory Standards, 2003.
Culture Media and Mycobacteria Special Interest Groups. Guidelines for assuring quality of solid media used in Australia for the cultivation of medically important mycobacteria. Australian Society for Microbiology, September 2004.
American Thoracic Society. Diagnosis and treatment of disease caused by non-tuberculous mycobacteria. [Review] Am J Respir Crit Care Med 1997;156:S1–S25.
Pfyffer GE, Bonato DA, Ebrahimzadeh A, Gross W, Hotaling J, Kornblum J, et al. Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. J Clin Microbiol 1999;37:3179–3186.
Woods GL, Bergmann JS, Witebsky FG, Fahle GA, Wanger A, Boulet B, et al. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. J Clin Microbiol 1999;37:1676–1682.
National Pathology Accreditation Advisory Council. Laboratory Accreditation Standards and Guidelines for Nucleic Acid Detection Techniques. Australian Government Department of Health and Ageing, 2000. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/health-npaac-docs-nad.htm/$FILE/nad.pdf Accessed on 17 January 2006.
Ridderhof JC, Williams LO, Legois S, Shult PA, Metchock B, Kubista LN, et al. Assessment of laboratory performance of nucleic acid amplification tests for detection of Mycobacterium tuberculosis. J Clin Microbiol 2003;41:5258–5261.
Piersimoni C, Scarparo C. Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples. J Clin Microbiol 2003;41:5355–5365.
Rapid diagnostic tests for tuberculosis. What is the appropriate use? American Thoracic Society Workshop. Am J Respir Crit Care Med 1997;155:1804–1814.
Centers for Disease Control and Prevention (CDC). Update: nucleic acid amplification tests for tuberculosis. MMWR Morb Mortal Wkly Rep 2000;49:593–594.
National Tuberculosis Advisory Committee. The BCG vaccine: information and recommendations for use in Australia. Manuscript in preparation.
Centers for Disease Control and Prevention. The role of BCG vaccine in the prevention and control of tuberculosis in the United States: a joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR Recomm Rep 1996;45(No. RR–4):1–18.
Downloads
Published
How to Cite
License
Copyright (c) 2006 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
